Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Therapy. Oncology|April 11, 2024
CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatmentKarin Teppert, Isabella Elias Yonezawa Ogusuku, Caroline Brandes, et al.
Journal for Immunotherapy of Cancer|July 21, 2021
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastomaFelix Zirngibl, Sara M Ivasko, Laura Grunewald, et al.
Cancers|April 3, 2021
CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-StimulusAna Textor, Laura Grunewald, Kathleen Anders, et al.
Frontiers in Immunology|July 16, 2021
A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy OptimizationLaura Grunewald, Tobias Lam, Lena Andersch, et al.
Frontiers in Immunology|December 15, 2025
Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma modelLena Andersch, Laura Grunewald, Maria Stecklum, et al.
Nature Communications|July 15, 2026
Oncogene inactivation-induced senescence facilitates tumor relapsePhilipp Schmitt, Katrin Hönig, Maria Teresa Norcia, et al.
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Nature Communications|December 9, 2025
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumorsMichael Launspach, Julia Macos, Shoaib Afzal, et al.
Pageof 2